22% INCREASE IN GROUP REVENUES; EBITDA EXCLUDING M&A AT € 104.1 MPOSITIVE MOMENTUM AND OUTLOOK FOR 2023DATA-DRIVEN PLATFORMS RESULTING IN LARGEST ALLIANCE IN TARGETED PROTEIN DEGRADATION IN THE INDUSTRYHAMBURG
EQS-News: Evotec SE / Key word(s): Annual ResultsEvotec SE preliminary fiscal year 2022 results: 'Ahead of the curve' – very strong performance in a challenging year 28.03.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. 22% INCREASE IN GROUP REVENUES; EBITDA EXCLUD.
Investegate |Evotec SE Announcements | Evotec SE: Evotec SE preliminary fiscal year 2022 results: Ahead of the curve – very strong performance in a challenging year investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.